The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2025 | Liquid biopsy in lymphoid malignancies: from genomics to MRD monitoring
In this video, Gianluca Gaidano, MD, PhD, University of Eastern Piedmont, Vercelli, Italy, shares insights into the value of using liquid biopsy to study lymphoid malignancies and tumors, highlighting its ability to provide a comprehensive view of the tumor and monitor its evolution over time. This interview took place at the 13th Annual Meeting of the Society of Hematologic Oncology (SOHO 2025) in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
